Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (24)

2019

  1. Monitoring the antimicrobial susceptibility of gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the smart study (Spain, 2016 and 2017)

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 145-155

2018

  1. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

2013

  1. Histological approach to Bacillus subtilis colony-biofilm: Evolving internal architecture and sporulation dynamics

    Histology and Histopathology, Vol. 28, Núm. 10, pp. 1351-1360

  2. Morphological plasticity of Streptococcus oralis isolates for biofilm production, invasiveness, and architectural patterns

    Archives of Oral Biology, Vol. 58, Núm. 11, pp. 1584-1593

  3. Qualitative and quantitative agar invasion test based on bacterial colony/biofilm

    Journal of Microbiological Methods, Vol. 94, Núm. 3, pp. 267-273

2010

  1. Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria

    International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144

2009

  1. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 6

2008

  1. High protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulation

    PLoS ONE, Vol. 3, Núm. 7

2005

  1. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747

2004

  1. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation

    Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 6, pp. 1148-1151

2001

  1. Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers

    International Journal of Antimicrobial Agents, Vol. 18, Núm. 3, pp. 231-238

2000

  1. Ex vivo bactericidal activity against group C Neisseria meningitidis in seronegative subjects

    Infection, Vol. 28, Núm. 5, pp. 305-308

1999

  1. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation

    Journal of Chemotherapy, Vol. 11, Núm. 5, pp. 345-348

1998

  1. EFECTO POSTANTIBIOTICO. FACTOR CON APLICACION CLINICA O SIMPLEMENTE CURIOSIDAD DE LABORATIORIO?

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 17, Núm. 1, pp. 40-43

  3. Estudio de la actividad bactericida de la combinación amoxicilina/ácido clavulánico y sus posibles efectos ante la resistencia a betalactámicos de Streptococcus pneumoniae

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 12-15

  4. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: A controlled study with vancomycin

    Antimicrobial Agents and Chemotherapy, Vol. 42, Núm. 7, pp. 1574-1577

1997

  1. Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 16, Núm. 7, pp. 512-516

  2. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: Implications for dosage regimens

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 6, pp. 1403-1405

  3. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: A phase I study

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 6, pp. 1389-1391